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The study is aimed at the preparation of isotretinoin (ITR) loaded bigel for acne therapy. Bigels were enriched with tea 
tree and jojoba oils known to bestowed soothing properties. Bigels were evaluated for the physiochemical parameters viz. 
pH, viscosity, etc, in vitro release, and ex vivo permeation. The results displayed enhanced retention and antimicrobial 
potential of optimized B2 gel when compared with plain gel and other formulations. Thus the bigel of isotretinoin could be a 
promising delivery system for the treatment of acne. 
Keywords: Acne, Bigel, Jojoba oil, Tea tree oil. 
IPC code; Int. cl. (2015.01)- A61K 9/00, A61K 36/00, A61P 17/10 
Introduction 
Acne vulgaris of the face is reported to be most 
common in the Indian population comprising ~1% of 
all dermatology patients1. The pathogenesis of acne is 
related to many factors, such as excess sebum 
production, overgrowth of Propionibacterium acnes 
in obstruction of the pilosebaceous unit, and 
inflammation induced by bacteria2. Many approaches 
have been used as well as many topical formulations 
developed to treat skin problems such as eczema, 
psoriasis, acne, and wound healing3. Thus, cosmetic 
manufacturers struggle to find ways to produce an 
effective product that matches all the needs of 
consumers4. The product should meet the need of all 
age groups and skin type. as well as environmental 
factors such as pollution along with the efficacy of the 
formulations5. A substantial number of shortcomings 
regarding cosmetic products has been reported 
comprising of instability and high sensitivity towards 
pH, temperature, light, and oxidation process as well 
as irritation and allergy upon application6. All these 
considerations have been a driving force for the 
development of new technology for manufacturers7. 
Recently it has been suggested that isotretinoin (ITR) 
should be used for the management of moderate-
severe acne8. ITR is a drug of choice in the treatment 
of all types of acne, including recalcitrant, severe and 
nodulocystic9. The most widely employed route of its 
administration is oral intake, but oral administration is 
reported to be associated with severe side-effects such 
as skin dryness and psychological disorders10. 
Consequently topical delivery, of ITR has been 
opined11. However, it is associated with several 
hiccups like irritation, erythema and peeling of the 
skin. Hence to overcome these side effects, the 
current study is embarked upon to develop of 
“optimized” Bigel of ITR. The developed system was 
characterized and evaluated for skin compliance, skin 
transport characteristics, and anti-acne potential12. 
Gels are semi-solid formulations and are broadly 
classified into hydrogel and organogel based on the 
nature of the continuous phase. Hydrogels have an 
aqueous phase system, while, organogel include a 
polar solvent as continuous phase12,13. Bigels are 
formulated by mixing of both aforementioned gels 
i.e., hydrogel and organogel in defined proportions. It
has been found that the drug release rates from the
organogels can be increased many folds by converting
the organogels into a bigel14. Bigels are soft solids
that belong to a class of interfacially jammed
emulsion gels15. These classes of biphasic gels are
quite unexplored and have been gaining attention in
the food as well as pharmaceutical industries as they
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hydrophilic drugs16. Due to the presence of hydrogels, 
these gels provide enhanced hydration of the stratum 
corneum thereby providing a cooling and 
moisturizing effect17 and are now being studied 
extensively. Tea tree oil (TTO) is an essential oil, 
steam-distilled from the plant Melaleuca alternifolia. It 
has a minimum content of terpinen-4-ol and a 
maximum content of 1, 8-cineole. Terpinen-4-ol is a 
major TTO component that exhibits strong antioxidant, 
anti-inflammatory properties and broad-spectrum 
antimicrobial activity against bacterial, viral, fungal, 
and protozoal infections affecting skin and mucosa18. 
Several studies have suggested the uses of TTO for the 
treatment of acne vulgaris, seborrheic dermatitis, and 
chronic gingivitis19. Jojoba (Simmondsia chinensis) is a 
long-lived, drought-resistant, perennial plant oil that is 
the main biological source of wax esters and has a 
multitude of potential applications20. Jojoba oil has an 
anti-inflammatory effect and can be used on a variety 
of skin conditions including skin infections, skin 
ageing, as well as wound healing21. Moreover, jojoba 
has been shown to play a role in cosmetic formulations 
such as sunscreens and moisturizers and also enhances 
the absorption of topical drugs22. 
 
Materials and Methods 
 
Materials 
Isotretinoin was obtained from Navketan Pharma, 
Aurangabad, India. Tea tree and jojoba oils were 
purchased from Sugandhco (P) Limited, Lucknow. 
Span 60 (S-60) was purchased from HiMedia 
Laboratories Pvt. Ltd., Mumbai, India. All chemicals 
were of analytical grade and were purchased from 
Himedia, Mumbai unless otherwise specified. 
 
Preparation and optimization of bigel 
Preparation of bigels involved a three-step process. 
The first process involved the development and 
optimization of the organogel and the second step 
comprised of the formulation and optimization of the 
hydrogel. The third step was the preparation of bigel by 
the dropwise addition of molten organogel in hydrogel. 
 
Preparation and optimization of organogel 
The preparation and optimization of organogel 
were based on critical gelling agent concentration. 
Organogel formulations were prepared by varying the 
concentrations (10, 15, 20, and 30 % w/w) of S-60, to 
decide critical gel concentration (the lowest 
concentration and viscosity at which organogel was 
first developed with good thermodynamic stability). 
Organogels were prepared by dissolving different 
concentration of S-60 in 80 g of jojoba oil and 5 g of 
tea tree oil. The mixing was carried out at 70 °C with 
a stirring speed of 500 RPM and subsequently cooled 
to 25 oC. ITR (0.05% w/w) loaded organogel was 
prepared in the same way and further mixed with 
hydrogel to form bigel. All the organogels were 
optimized based on thermodynamic stability and low 
viscosity (Suppl. Table 1). 
 
Preparation and optimization of hydrogel 
Hydrogel (1% w/w) was prepared by soaking the 
weighed quantity of carbopol (1 g) in the required 
quantity of distilled water as per the established 
method23 the author’s lab. The stable hydrogel was 
formed after occasional stirring. 
 
Preparation of bigel 
Bigels were prepared by dropwise addition of 
molten organogel in carbopol hydrogel (70 °C,  
500 RPM) until a homogenous mixture was obtained. 
Based on the composition, the mixture either formed a 
bigel or remained as a phase-separated system when 
cooled to room temperature. Ten formulations were 
developed by varying the composition of organogel 
and hydrogel with (B-1 to B-5) and without 
isotretinoin (DB-1 to DB-5) (Suppl. Table 2). The 
bigel formation was confirmed by tube inversion test 
(Suppl. Fig. 1). 
 
Characterization of bigel 
 
Drug-excipient compatibility study 
The chemical interactions between the drug and 
components of the bigels were analyzed using Fourier 
Transform Infrared Spectroscopy (FTIR) (FTIR- 
8400S Shimadzu, Japan). The FTIR Spectrum of ITR 
along with excipients such as carbopol 934 and span 
60 were observed and analyzed.  
 
Physical appearance 
The physical appearance of the bigel formulations 
was visually observed for change in colour, 
homogeneity, consistency, and phase separation. Tube 
inversion test was also carried out to confirm the 
development of bigel. 
 
Determination of pH and viscosity 
The pH of the bigel formulations was determined 
by using a digital pH Meter (NIG333, New Delhi). 
For pH determination, bigel (0.1 g) was suitably 
diluted with distilled water and then the pH of the 
solution was measured.  




The viscosity of bigels was studied using a digital 
Viscometer (Labsonic LT-730). Bigel (30 g) was kept 
in a beaker. Viscosity was determined using spindle 
no. 4 at a velocity of 60 rpm. The Experiments were 
done in triplicate at room temperature. 
 
Leaching of oil 
The leaching of the internal phase was qualitatively 
studied using the filter paper method. Square slabs of 
1.9 cm diameter of all five formulations (B-1 to B-5) 
and hydrogel was kept on a filter paper and incubated 
at 37 °C for 24 hours. The quantification of the 




The microarchitecture and the nature of the bigel 
were determined using a Fluorescent Microscope 
(Nikon Eclipse). The bigels for the fluorescence 
microscopy were prepared by dissolving fluoresce in 
isothiocyanate dye (FITC 0.1% w/w) in organogel. 
The organogels in the molten state were mixed with 
hydrogel to form dye loaded bigels. The prepared 
samples were analyzed by fluorescence microscopy. 
 
Thermal properties 
The melting points (Tm) and the thermal profiles of 
the developed bigels were analyzed using a 
differential scanning Calorimeter (Pyris Diamond 
TG/DTA, PerkinElmer (Singapore). A platinum 
crucible was used with alpha alumina powder as a 
reference. The analysis was performed under a 
nitrogen environment maintained at a flow-rate of  
150 mL/min.  
 
Drug content  
The drug content of bigel was determined by 
dissolving the 0.1 g of bigel in the 5 mL of methanol. 
The solution was mixed followed by vortexing for 5 
minutes and filtered. The absorbance was measured 
using a UV-Visible Spectrophotometer (Labtronics 
Model LT-2910) at 332 nm to calculate the content 
ITR in bigel. 
 
Texture analysis 
Bigels were analyzed for hardness, adhesiveness, 
spreadability, and extrudability using CT3 Texture 
Analyzer (Brookfield Engineering Laboratories, 
USA). For the study of hardness and adhesiveness, 
TA 10 probe and TA-BT-KI fixture were used by 
filling the bigel (30 g) in a beaker. The TA 10 probe 
was allowed to compress into the sample (speed of 1 
mm/s to a depth of 30 mm) with a trigger load of 4 g 
to complete 1 cycle of the experiment. The hardness 
was noted in term of force required to deform the 
bigel. The spreadability of bigels was measured by 
using a male and female cone-type probe and 
extrudability was determined by the TA-DEC probe. 
The experiment was performed for a comparative 
study of bigel formulations vs marketed gel. Data 
were generated using Texture Pro CTV1.3 software. 
 
In-vitro drug release studies 
A modified Franz’s diffusion cell was used to study 
the in-vitro release profiles of ITR from the  
bigels (3.14 cm2 area and 20 ml volume). The release 
studies were carried out in phosphate buffer (pH 7.2). 
Weighed quantity of (0.5 g) of bigel was placed in a 
formerly activated dialysis membrane mounted 
between the receptor and donor compartment. The 
donor compartment was filled with 20 mL of the 
buffer as dissolution media, kept on stirring at 100 
rpm and the temperature was maintained 32±1 °C. 
Samples were collected at regular time intervals over 
a period of 24 hours and analyzed at 332 nm using a 
UV-Visible spectrophotometer. Experiments were 
done in triplicate. 
 
Release kinetics study 
The drug release data of the formulations (bigel) 
was plotted using various kinetic models i.e. zero 
order, first order. Higuchi's kinetics and Korsmeyer's 
equation to evaluate the drug release mechanism and 
kinetics as mentioned in literature.  
 
Ex-vivo permeation and ex-vivo retention studies 
The experiment was carried out in Franz diffusion 
assembly using goatskin (obtained from the local 
slaughterhouse, Lucknow), with the optimized 
formulation (B-2) in triplicates. Hair was removed 
carefully with an electric applicator and the skin was 
rinsed with physiological phosphate buffer (pH 7.2). 
The adhering fatty tissues below the skin were 
removed using isopropyl alcohol. The skin section 
was clamped between the donor and the receptor 
chamber of the vertical diffusion cell with an effective 
diffusion area of 3.14 cm2 and a cell volume of  
20 mL. The receptor chamber was filled with a 
freshly prepared mixture of physiological PBS  
(pH 7.2). The diffusion cells were maintained at  
37±0.5 °C using a recirculating water bath and the 
fluid in the receptor chamber was stirred continuously 
at 300 rpm on a magnetic stirrer. Accurately weighed 




1.0 g of the gel was placed in the donor chamber. 
Samples (2 mL) were withdrawn at a regular time 
interval, and the same volume of PBS (pH 7.2) was 
added to maintain the sink condition and then 
analyzed at 332 nm using a UV-visible 
spectrophotometer. Experiments were performed in 
triplicate. 
 
Ex-vivo antimicrobial Studies 
The antimicrobial activity of optimized bigel (B-2) 
and conventional formulation (10 mg/mL) was carried 
out against Staphylococcus aureus, one of the bacteria 
responsible for causing acne, using the disc diffusion 
method. The Kirby-Bauer test was used to determine 
the zone of inhibition25. The concentrations of each 
formulation were incorporated into the filter paper 
discs and the disc of each formulation was placed into 
the agar medium for 24 hours at 37 °C. It gave a clear 
zone of inhibition around the disc, indicating the 
antimicrobial activity of the formulations. The zones 
of inhibition so obtained were measured, and the 
results were compared. This study was performed in 
triplicate for each formulation. 
 
Stability studies 
The accelerated stability of the bigels was carried out 
by the freeze-thaw method. In this method, bigels were 
alternatively kept at -20 oC (freezing) and 70 oC 
(thawing) for 15 min. The study was performed for 5 
cycles, and the bigels were checked visually for any 
signs of destabilization (phase separation) after each 
cycle. The bigels were allowed to reach room 
temperature upon completion of five cycles and finally 
evaluated for their organoleptic characteristics along 
with drug content and pH. The long-term stability of 
bigels was estimated by incubating the weighed samples 
at 30±2.0 oC and 65% RH ± 5% RH for 3 months. The 
bigels were observed for any changes in the visual 
appearances (e.g. colour change, phase separation or 
syneresis) and drug content at regular intervals of time 
(0, 10, 30, 60, and 120 days respectively). 
 
Result and Discussion 
Based on the literature reported, different organogel 
formulations were prepared by varying the 
concentrations of SP-60 to decide critical gel 
concentration i.e., the lowest concentration at which 
organogel was first developed and which has the lowest 
viscosity and thermodynamic stability (Suppl. Table 1). 
The organogel containing 15% w/w SP-60 was found to 
be optimized as it displayed no signs of phase 
separation, low viscosity, and thermodynamic stability. 
Characterization of bigel 
Drug-excipient compatibility study 
In Suppl. Fig. 2a, ITR was characterized by bands 
around 1700–1500 and 1300–1100 cm-1 that 
correspond to C=O and C–O stretching vibrations. 
The IR spectrum of ITR along with the excipients 
present in the bigel closely resembles the IR spectrum 
of ITR, carbopol 934, SP-60. The characteristic bands 
of ITR present with reduced intensity as shown in the 
FTIR spectrum of bigel probably due to the restriction 
inside the formulation matrix. The absorption band at 
3400 cm-1 due to hydroxyl stretching was not affected 
in the formulation, which emphasized the absence of 
any possible interaction between the drug and the 
formulation components used. 
 
Physical appearance 
The prepared bigel formulations (Suppl. Table 2) 
were visually tested for colour, physical appearance, 
homogeneity, and texture. The physicochemical 
properties of the gel formulations are given in Suppl. 
Table 3. The results displayed B-1 and B-2 bigel 
formulation possessed good homogeneity, 
smoothness and texture with no phase separation as 
compared to other prepared bigels. Therefore, the 
two physiochemical stable bigels B-1 and B-2 were 
taken for further studies and formulations B-3, B-4, 
and B-5 were dropped out. Further fluorescence 
microscopy of these samples was performed. The 
droplet size and population of bigels are shown in 
Suppl. Fig. 3. The fluorescent micrographs showed 
non-uniformly distributed spherical droplets. The 
droplets were smaller and lesser in number in the 
bigels containing lower proportions of the organogel. 
The dispersed droplets showed green fluorescence, 
suggesting the presence of organogel as the 
dispersed droplets indicating the formation of 
oil/water emulsion gel. 
 
pH and viscosity measurement 
The pH of all the gel formulations was in the range 
of 6.5 to 7.0, which lies in the normal pH range of the 
skin and would not produce any skin irritation26. 
There was no significant change in pH values as a 
function of time for all formulations.  
The viscosity of the bigels increases with an 
increase in the concentration of organogel as shown 
in Supplementary Table 3. The increase in viscosity 
could be attributed to a higher concentration  
span-60 giving physical strength and stability of 
organogel27. 




Leaching of oil from bigel 
The leaching of the internal phase was qualitatively 
studied using the filter paper method. Hydrogel B1 
and B2 displayed no signs of leaching, however, 
hydrogels B3, B4, and B5 displayed leaching in a 
range of 1.4±0.5, 2.2±0.3, and 2.7±0.4 cm 
respectively (Suppl. Table 3). This could be attributed 
to the formation of a rigid gel network of the system 
towards which oil displayed higher affinity and 




An increase in the melting points of the bigels was 
observed with an increase in the proportion of the 
organogel of B-1 and B-2. An increase in the solid 
component is associated with the increase in the 
orderliness at the molecular level29. Hence, a higher 
amount of energy is required. From the results, it may 
be assumed that the bigels prepared with higher 
proportions of organogel lead to the formation of 
formulations with higher thermodynamic stability 
(Suppl. Fig. 4). 
 
Drug content and texture analysis 
The drug content of all the formulation was found 
to be in a range of 92.1±2.33 to 98.85±0.13 (Suppl. 
Table 3). Formulation B-1 and B-2 displayed 
extrudability of 318.8±2.44 and 315.0±3.11 mJ 
respectively. The adhesive force was found to be 
215.66±2.13 and 242.33±1.99 g and spreadability of 
5.0±0.3 and 7.6±0.5 respectively. The texture analysis 
profile is shown in Suppl. Table 4. The adhesive force 
of B-2 was found high when compared to B-1, while 
B-2 showed good sticky behaviour with high 
spreadability, less hardness, and a little difference in 
extrudability (easy to extrude the formulation from 
the packaging of the formulation) led to an optimized 
formulation B-2 (Suppl. Table 4). 
 
In-vitro drug release profile and release kinetics 
A significantly (P >0.05) higher release of 
80±3.22% was displayed from B-2 when compared 
with 60±2.31% of conventional gel. The release was 
diffusion mediated release which could prove to be a 
better topical delivery (Suppl. Fig. 5). The prepared 
bigel follow Korsmeyer-peppas model indicating the 
release to be diffusion mediated30 (Suppl. Table 4). 
 
Ex-vivo permeation and retention studies 
Ex-vivo per cent permeation was found to be 
54.05±2.31% of the optimized formulation B-2 and 
41.48±3.22% of conventional gel which indicated that 
a less percentage of the drug was permeated in 
comparison to conventional gel over a period of 24 
hours and was diffusion mediated with a permeation 
flux of 0.903 J. However, an ex-vivo retention study of 
the optimized bigel formulation after 24 hours 
displayed retention of 23±2.0% drug on the dermal 
layer. This gives auxiliary evidence that the 
formulation is suitable for topical delivery as the 
retention aids in enhancing local effect31(Suppl. Fig. 6). 
 
Ex-vivo antimicrobial studies 
The formulation displayed a significantly higher  
(P >0.05) zone of inhibition when compared to 
conventional gel. The zone of inhibition was found to 
be 32±0.127 and 17±0.513 mm for bigel and 
conventional gel respectively after an incubation 
period of 48 hours. 
 
Stability studies 
The formulations were subjected to short term 
stability through a freeze-thaw cycle (5 cycles) and no 
significant difference in drug content, physical 
appearance, and pH of the bigel was observed (Suppl. 
Table 5). This indicates that the formulation possesses 
good stability at different temperatures. Further, the 
optimized batch B-2 was subjected to long term 
stability and stored in vials at 30ºC±2ºC over a period 
of 120 days. The formulation revealed no significant 
change in the aforementioned physicochemical 
characteristics. However, Drug content and the pH 
value insignificantly decreased with time at 
temperature 30ºC±2ºC. The result of the stability 
study suggests the ITR bigel B-2 can be used for a 
long time and can be kept at room temperature. The 
method of preparation was facile, reproducible, and 
suitable for scale-up. 
 
Conclusion 
The current study is based on an easy and 
economical method for novel bigels preparation. The 
bigels with higher proportions of organogel were 
smooth, stable and biocompatible in nature and 
showed higher viscosity. The bigels with lower 
proportions of organogel showed higher drug release 
following diffusion mediated Korsemeyer Peppas 
model which is ideal for a diffusion mediated release 
system. Hydrogel present in it reduces the dryness  
(as a side effect) of the drug. The developed bigels 
may be tried as matrices for topical delivery of an 
antiacne drug. It is expected that the two gel systems 




in bigels may synergize enhancement of hydration of 
stratum corneum, moisturizing effect, spreadability, 
and drug penetration as desired for topical 
application. 
 
Conflict of interest 
The authors declare no conflict of interest 
 
References 
1 Bhavsar B, Choksi B, Sanmukhani J, Dogra A and Haq R, 
Clindamycin 1% nano-emulsion gel formulation for the 
treatment of acne vulgaris: results of a randomized, active 
controlled, multicentre, phase IV clinical trial, J Clin Diagn 
Res, 2014, 8, YC05. 
2 Nishijima S, Kurokawa I, Katoh N and Watanabe K., The 
bacteriology of acne vulgaris and antimicrobial 
susceptibility of Propionibacterium acnes and 
Staphylococcus epidermidis isolated from acne lesions, J 
Dermatol, 2000, 27, 318-23. 
3 Prasad S, Mukhopadhyay A and Kubavat A, Efficacy and 
safety of a nano-emulsion gel formulation of adapalene 0.1% 
and clindamycin 1% combination in acne vulgaris: A 
randomized, open label, active-controlled, multicentric, 
phase IV clinical trial, Indian J Dermatol Venereol Leprol, 
2012, 78, 459. 
4 Wang P, Tang H and Zhang P, Highly efficient and 
biocompatible nanoparticle-based photosensitizer for treatment 
of acne vulgaris, Nanomedicine, 2018, 13, 2629-36. 
5 Khalid N, Che Wel C, Alam SS and Mokhtaruddin S, 
Cosmetic for modern consumer: The impact of selfcongruity 
on purchase intention, Int J Asian Soc Sci, 2018, 8, 34-41. 
6 Kale S N and Deore S L, Emulsion micro emulsion and nano 
emulsion: A review, Sys Rev Pharm, 2017, 8, 39. 
7 Nast A, Dreno B and Bettoli V, European evidence‐based 
(S3) guidelines for the treatment of acne, J Eur Acad 
Dermatol Venereol, 2012, 26, 1-29. 
8 Ramli S, Chyi K, Zainuddin N, Mokhtar W and Rahman A, 
The Influence of Surfactant/Co-Surfactant Hydrophilic-
Lipophilic Balance on the Formation of Limonene-Based 
Microemulsion as Vitamin C Carrier. Sains Malays, 2019, 
48, 1035-42. 
9 Shah SK and Alexis AF, Acne in skin of color: practical 
approaches to treatment J Dermatol Treat, 2010, 21, 206-11. 
10 Raza K, Singh B, Singal P, Wadhwa S and Katare O P, 
Systematically optimized biocompatible isotretinoin-loaded 
solid lipid nanoparticles (SLNs) for topical treatment of acne, 
Colloids Surf B, 2013, 105, 67-74. 
11 Liu J, Hu W, Chen H, Ni Q, Xu H and Yang X, Isotretinoin-
loaded solid lipid nanoparticles with skin targeting for topical 
delivery, Int J Pharm, 2007, 328, 191-5. 
12 Layegh P, Mosallaei N, Bagheri D, Jaafari M R and 
Golmohammadzadeh S, The efficacy of isotretinoin-loaded 
solid lipid nanoparticles in comparison to Isotrex® on acne 
treatment, Nanomed J, 2013, 1, 38-47. 
13 Di Michele L, Fiocco D, Varrato F, Sastry S, Eiser E and 
Foffi G, Aggregation dynamics, structure, and mechanical 
properties of bigels, Soft matter, 2014, 10, 3633-48. 
14 Sagiri S, Behera B and Rafanan R, Organogels as matrices 
for controlled drug delivery: A review on the current state, 
Soft Materials, 2014, 12, 47-72. 
15 Behera B, Singh V and Kulanthaivel S, Physical and 
mechanical properties of sunflower oil and synthetic 
polymers based bigels for the delivery of nitroimidazole 
antibiotic–A therapeutic approach for controlled drug 
delivery, Eur Polym J, 2015, 64, 253-64. 
16 Wakhet S, Singh V K and Sahoo S, Characterization of 
gelatin–agar based phase separated hydrogel, emulgel and 
bigel: A comparative study, J Mater Sci Mater, 2015,  
26, 118. 
17 Rehman K, Amin M C I M and Zulfakar M H, Development 
and physical characterization of polymer-fish oil bigel 
(hydrogel/oleogel) system as a transdermal drug delivery 
vehicle, J Oleo Sci, 2014, ess14101. 
18 Halcón L and Milkus K, Staphylococcus aureus and wounds: 
A review of tea tree oil as a promising antimicrobial, Am J 
Infect Control, 2004, 32, 402-8. 
19 Pazyar N, Yaghoobi R, Bagherani N and Kazerouni A,  
A review of applications of tea tree oil in dermatology, Int J 
Dermatol, 2013, 52, 784-90. 
20 Lin T-K, Zhong L and Santiago J L, Anti-inflammatory and 
skin barrier repair effects of topical application of some plant 
oils, Int J Mol Sci, 2018, 19, 70. 
21 El Mogy N S, Medical effect of Jojoba Oil in the treatment 
of skin diseases, Google Patents, 2004. 
22 Rawlings A and Lombard K, A review on the extensive 
skin benefits of mineral oil, Int J Cosmet Sci, 2012, 34, 
511-8. 
23 Parashar P, Pal S, Dwivedi M and Saraf S A, Augmented 
Therapeutic Efficacy of Naringenin Through Microemulsion-
Loaded Sericin Gel Against UVB-Induced Photoaging, 
AAPS Pharm Sci Tech, 2020, 21(6), 1-13 
24 Bordenave N S, Janaswamy and Yao Y, Influence of 
glucan structure on the swelling and leaching properties 
of starch microparticles, Carbohydrate polymers, 2013, 
103, 234-243. 
25 Ruparelia J P, Chatterjee A K, Duttagupta S P and Mukherji S, 
Strain specificity in antimicrobial activity of silver and 
copper nanoparticles, Acta Biomater, 2008, 4(3), 707-716. 
26 Pal R R, Parashar P, Singh I and Saraf S A, Tamanu oil 
potentiated novel sericin emulgel of levocetirizine: 
repurposing for topical delivery against DNCB-induced 
atopic dermatitis, QbD based development and in vivo 
evaluation, J Microencapsul, 2019, 36, 432-46. 
27 Cok M, Viola M and Vecchies F, N-isopropyl chitosan,  
A pH-and thermo-responsive polysaccharide for gel 
formation, Carbohydr Polym, 2020, 230, 115641. 
28 Singh B and Kumar R, Designing biocompatible sterile 
organogel–bigel formulations for drug delivery applications 
using green protocol, New J Chem, 2019, 43, 3059-70. 
29 Javed H, Shah SNH and Iqbal FM, Formulation development 
and evaluation of diphenhydramine nasal nano-emulgel, 
AAPS Pharm Sci Tech, 2018, 19, 1730-43. 
30 Singh N, Parashar P, Tripathi CB, Kanoujia J, Kaithwas G 
and Saraf SA, Oral delivery of allopurinol niosomes in 
treatment of gout in animal model, J Liposome Res, 2017, 27, 
130-8. 
31 Gómez-Segura L, Parra A, Calpena-Campmany AC,  
Gimeno Á, Gómez de Aranda I and Boix-Montañes A, Ex 
vivo permeation of carprofen vehiculated by PLGA 
nanoparticles through porcine mucous membranes and 
ophthalmic tissues, Nanomaterials, 2020, 10, 355. 
